The rise of passive investing is making markets “less efficient and more fragile”, says Tom Stevenson in The Telegraph. Somewhere between a third and half of equity assets under management are now passive, meaning they are held by funds seeking to track market indexes without trying to beat them. Passive investing offers lower fund manager fees than the active variety.
The problem? Too much passive investing makes for less discerning capital allocation, with money blindly pouring into markets according to “fund flows” and “weightings”. Share prices are thus prone to becoming disconnected from reality – although more inefficient markets do at least open the way for active stock pickers to spot mispricing opportunities and scoop up bargains.
Are ETFs following?
A new generation of actively managed exchange-traded funds (ETFs) is trying to do just that, says The Economist. Inflows into “active” ETFs have surged from less than $5 billion in 2019 to over $100 billion last year. Investors should be wary. ETFs have revolutionised markets.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
But active ETFs are undoing that progress, charging high fees in exchange for complicated promises of “volatility protection”, or exposure to illiquid assets in private equity and debt. They are usually a “rip-off”. Another popular trend is “thematic” ETFs, which let investors play everything from pet care to Chinese cloud computing, says James Mackintosh in The Wall Street Journal. But the approach is failing.
Artificial intelligence (AI) has dominated markets for most of this year, yet AI-themed ETFs have actually underperformed the US and global stock benchmarks (you would have done better by just buying Nvidia). Three AI ETFs even managed to shed value in 2024 – picking the right theme at the right time and still losing money must be “galling”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
-
HMRC confirms crypto ETN ISA rulesWith crypto ETNs now technically available for UK retail investors, HMRC has confirmed they can be held in an ISA – but there’s a complication
-
Pensioners targeted in fine wine scams – the tactics to watch forWine has emerged as the latest lure in investment fraud, with pensioners being specifically targeted by scammers
-
Pierre-Édouard Stérin wants to make France great againConservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Global investors have overlooked the top innovators in emerging marketsOpinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Pinewood Technologies: a drive for growthPinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summerThe US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with folliesThe best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuationAEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefullyShares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?
